Drug binding to HERG channels: evidence for a 'non-aromatic' binding site for fluvoxamine
about
QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy.In silico analysis of conformational changes induced by mutation of aromatic binding residues: consequences for drug binding in the hERG K+ channelInhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of actionMolecular mechanisms for drug interactions with hERG that cause long QT syndrome.Differential hERG ion channel activity of ultrasmall gold nanoparticles.Block of HERG k channel by classic histamine h(1) receptor antagonist chlorpheniramine.Citalopram and cardiac toxicity.Allosteric effects of erythromycin pretreatment on thioridazine block of hERG potassium channels.Cardiotoxicity screening: a review of rapid-throughput in vitro approaches.Development and Comparison of hERG Blocker Classifiers: Assessment on Different Datasets Yields Markedly Different Results.Interactions at human ether-à-go-go-related gene channels.Interactions between amiodarone and the hERG potassium channel pore determined with mutagenesis and in silico docking.Physicochemical features of the HERG channel drug binding site.Blockade of the human ether-a-go-go-related gene potassium channel by ketamine.Probing the molecular basis of hERG drug block with unnatural amino acids.
P2860
Q24796217-71F773E2-5AD1-4CC2-8F64-59AF9EA90284Q27311255-445556E3-DAE3-47A0-BB3C-560F9757B3C1Q35047162-3A825267-2D75-4B59-956C-97B894DDE027Q36545039-D7845858-D060-41E5-A52F-F89EAB5F3591Q36855377-578A18A7-B279-4887-9ECA-6000C665FD20Q37398466-5C224568-42C3-4CCF-A9E9-39C9F4184DA8Q38045165-DFC59DB5-136E-443C-8F54-BDE7D2706819Q38529440-3C45D072-5949-41C1-A0A5-B9ABDAD892BEQ38671689-07777C43-0B19-422F-A7D4-22DE29B5CC07Q39551118-0D56B49C-AA79-474E-8F61-FB8782DB35A4Q39752399-E59EFE4F-947A-4A26-9B90-F83D271A360BQ42173245-B3311C8A-CECB-40AF-9349-A7F586FB9520Q44709094-12FF7A02-80F3-4FBC-8B7C-D68262D1007AQ47828303-D3C4FB17-39A5-48A5-A379-AB0CC428D13FQ48267422-F680BC6D-1C1A-486F-8A4C-2AB9EE0D4D98
P2860
Drug binding to HERG channels: evidence for a 'non-aromatic' binding site for fluvoxamine
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Drug binding to HERG channels: evidence for a 'non-aromatic' binding site for fluvoxamine
@ast
Drug binding to HERG channels: evidence for a 'non-aromatic' binding site for fluvoxamine
@en
type
label
Drug binding to HERG channels: evidence for a 'non-aromatic' binding site for fluvoxamine
@ast
Drug binding to HERG channels: evidence for a 'non-aromatic' binding site for fluvoxamine
@en
prefLabel
Drug binding to HERG channels: evidence for a 'non-aromatic' binding site for fluvoxamine
@ast
Drug binding to HERG channels: evidence for a 'non-aromatic' binding site for fluvoxamine
@en
P2860
P356
P1476
Drug binding to HERG channels: evidence for a 'non-aromatic' binding site for fluvoxamine
@en
P2093
John S Mitcheson
P2860
P304
P356
10.1038/SJ.BJP.0705336
P407
P577
2003-07-01T00:00:00Z